Skip to main navigation Skip to search Skip to main content

Corrigendum to: “Prevalence of Potential Drug Interactions With Direct-Acting Antivirals for COVID-19 Among Hospitalized Patients” [Clin Ther 2024;46:778–784] (Clinical Therapeutics (2024) 46(10) (778–784), (S0149291824002157), (10.1016/j.clinthera.2024.08.004))

  • Essy Mozaffari
  • , Aastha Chandak
  • , Andrew Ustianowski
  • , Christina G. Rivera*
  • , Neera Ahuja
  • , Heng Jiang
  • , Mark Berry
  • , Jason F. Okulicz
  • , Alpesh N. Amin
  • *Corresponding author for this work

Research output: Contribution to journalComment/debate

Abstract

The authors regret that an incorrect value of “1219544” was reported for the number of participants in the 50 to 64 year age group in Table 1. The correct number of participants in the 50 to 64 year age group in the study was “219544.” The authors would like to apologise for any inconvenience caused.

Original languageEnglish
Pages (from-to)178
Number of pages1
JournalClinical Therapeutics
Volume47
Issue number2
DOIs
StatePublished - Feb 2025
Externally publishedYes

Fingerprint

Dive into the research topics of 'Corrigendum to: “Prevalence of Potential Drug Interactions With Direct-Acting Antivirals for COVID-19 Among Hospitalized Patients” [Clin Ther 2024;46:778–784] (Clinical Therapeutics (2024) 46(10) (778–784), (S0149291824002157), (10.1016/j.clinthera.2024.08.004))'. Together they form a unique fingerprint.

Cite this